Management of Poststroke Hyperglycemia: Results of the TEXAIS Randomized Clinical Trial

BACKGROUND: Hyperglycemia in acute ischemic stroke reduces the efficacy of stroke thrombolysis and thrombectomy, with worse clinical outcomes. Insulin-based therapies are difficult to implement and may cause hypoglycemia. We investigated whether exenatide, a GLP-1 (glucagon-like peptide-1) receptor...

Descripción completa

Detalles Bibliográficos
Autores principales: Bladin, Christopher F., Wah Cheung, Ngai, Dewey, Helen M., Churilov, Leonid, Middleton, Sandy, Thijs, Vincent, Ekinci, Elif, Levi, Christopher R., Lindley, Richard, Donnan, Geoffrey A., Parsons, Mark W., Meretoja, Atte, Tiainen, Marjaana, Choi, Philip M.C., Cordato, Dennis, Brown, Helen, Campbell, Bruce C.V., Davis, Stephen M., Cloud, Geoffrey, Grimley, Rohan, Lee-Archer, Matthew, Ghia, Darshan, Sanders, Lauren, Markus, Romesh, Muller, Claire, Salvaris, Patrick, Wu, Teddy, Fink, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Clinical Trials
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10664794/
https://www.ncbi.nlm.nih.gov/pubmed/38011235
http://dx.doi.org/10.1161/STROKEAHA.123.044568

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10664794/
https://www.ncbi.nlm.nih.gov/pubmed/38011235
http://dx.doi.org/10.1161/STROKEAHA.123.044568

Ejemplares similares